Skip to main content

Month: July 2023

Vertex to Announce Second Quarter 2023 Financial Results on Wednesday, August 9, 2023

KING OF PRUSSIA, Pa., July 17, 2023 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release second quarter 2023 financial results before the market opens on Wednesday, August 9, 2023. A conference call to discuss the results will be held at 8:30 a.m. Eastern Time that same day. Those wishing to participate may do so by dialing 1-201-689-8471 approximately ten minutes prior to start time. A listen-only webcast of the call will also be available through the Company’s Investor Relations website at https://ir.vertexinc.com. A conference call replay will be available approximately one hour after the call by dialing 1-412-317-6671 and referencing passcode 13739853, or via the Company’s Investor Relations website. The replay will expire on August...

Continue reading

Clearmind Medicine Announces Share-Based Payment for the Company’s Consultants

Tel Aviv, Israel / Vancouver, Canada, July 17, 2023 (GLOBE NEWSWIRE) —  Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has issued 17,899 common shares in the capital of the Company (“Shares”) in lieu of the final payment of $10,000, starting May 1st 2022, to consultants of the Company. In addition, the Company has issued restricted stock units (“RSUS”) for additional consultant in lieu of payment of $5,000. All Shares will only be subjected to those restrictions designated in applicable securities laws. About Clearmind Medicine Inc. Clearmind is a psychedelic pharmaceutical biotech company...

Continue reading

CrossAmerica Partners to Announce Second Quarter 2023 Earnings Results on August 7

Allentown, PA, July 17, 2023 (GLOBE NEWSWIRE) — CrossAmerica Partners to Announce Second Quarter 2023 Earnings Results on August 7 ALLENTOWN, PA, July 17, 2023 – CrossAmerica Partners LP (NYSE: CAPL) today announced that it will release its second quarter 2023 results after the market closes on Monday, August 7, 2023. In conjunction with the news release, management will host a conference call on Tuesday, August 8 at 9:00 a.m. Eastern Time. The conference call numbers are 888-396-8049 or 416-764-8646 and the passcode for both is 70854269. A live audio webcast of the conference call and the related earnings materials, including reconciliations of any non-GAAP financial measures to GAAP financial measures and any other applicable disclosures, will be available on that same day on the investor section of the CrossAmerica website...

Continue reading

Berry Corporation Announces Acquisition of Macpherson Energy Corporation

Attractively Priced Acquisition of Oil Producing Assets Reflects Disciplined Capital Returns Strategy to Deliver Enhanced Free Cash Flow DALLAS, July 17, 2023 (GLOBE NEWSWIRE) — Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) announced today that it has executed a definitive agreement to acquire Macpherson Energy Corporation, a privately held Kern County, California operator, for $70 million in cash, subject to customary purchase price adjustments. The transaction is structured such that $50 million will be paid at closing and the remainder paid in July 2024. This is a value creating transaction for Berry and our shareholders that we expect to be fully paid for by mid-year 2024 based on current projections for the pro forma company and $75/barrel Brent pricing. Substantially all of the purchase price will come...

Continue reading

Royalty Pharma Declares Third Quarter 2023 Dividend

NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2023 of $0.20 per Class A ordinary share. The dividend will be paid on September 15, 2023, to shareholders of record at the close of business on August 18, 2023. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s...

Continue reading

CrossFirst Bankshares, Inc. Reports Second Quarter 2023 Results

LEAWOOD, Kan., July 17, 2023 (GLOBE NEWSWIRE) — CrossFirst Bankshares, Inc. (Nasdaq: CFB), the bank holding company for CrossFirst Bank, today reported operating results for the second quarter ended June 30, 2023. The second quarter earnings release can be viewed here: https://investors.crossfirstbankshares.com/financials/quarterly-reports CrossFirst Bankshares, Inc. will host a conference call to review second quarter results on Tuesday, July 18, 2023, at 10 a.m. CT / 11 a.m. ET. To access the event by telephone, please dial (844) 481-2831 at least fifteen minutes prior to the start of the call and request access to the CrossFirst Bankshares call. International callers should dial +1 (412) 317-1851 and request access as directed above. The event will also be broadcast live over the internet and can be accessed via the following...

Continue reading

PrairieSky Announces 2023 Second Quarter Results, Including Record Oil Royalty Production

CALGARY, Alberta, July 17, 2023 (GLOBE NEWSWIRE) — PrairieSky Royalty Ltd. (“PrairieSky” or the “Company“) (TSX: PSK) is pleased to announce its second quarter (“Q2 2023“) results for the three-month period ended June 30, 2023. Second Quarter Highlights:Record quarterly average oil royalty production of 12,607 barrels per day, a 3% increase over Q1 2023 and Q2 2022 with total royalty production averaging 23,517 BOE per day. Revenues totaled $117.4 million, 7% lower than Q1 2023 and 41% below Q2 2022, comprised of royalty production revenues of $108.4 million and other revenues of $9.0 million. Quarterly funds from operations of $91.3 million ($0.38 per common share, basic and diluted) were driven by oil royalty production growth and were 6% above Q1 2023 and 43% below Q2 2022. Declared a second...

Continue reading

Northann Corp. Appoints David M. Kratochvil as Chief Financial Officer

NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) — Northann Corp., a technology innovator, producer of natural and sustainable material-based products for interior finishes, today announced the appointment of David M. Kratochvil as its new Chief Financial Officer, effective July 14, 2023. Kratochvil brings more than 25 years of international, transactional, and Wall Street experience to the Northann Corp. team. With an extensive background in strategic and operational finance, coupled with significant capital markets knowledge, he will be integral as the company continues its journey in advancing innovation and sustainability. “We are thrilled to have David join our team. His blend of financial acumen, strategic insight, and executive leadership will help drive Northann’s development, revenue growth, and will help build our team as we...

Continue reading

Baltic Horizon Fund publishes its NAV for June 2023

The net asset value (NAV) of the Baltic Horizon Fund (the Fund) unit at the end of June 2023 amounted to EUR 0.9905 per unit. Compared to the previous month, NAV per unit decreased by 10.4%. The total net asset value of the Fund amounted to EUR 118.5 million over the month. The NAV decrease was mainly affected by the mid-year revaluation of investment properties. The EPRA NRV as of 30 June 2023 was EUR 1.0208 per unit, corresponding to a decrease of 11.8% over the last month. At the end of June 2023, new portfolio valuations were conducted by an independent real estate appraiser Colliers. As of 30 June 2023, the fair value of the Baltic Horizon Fund portfolio decreased to EUR 255.7 million (like-for-like portfolio as of 31 December 2022: 268.9 million). Compared to the previous valuations, the change in portfolio value was mainly driven...

Continue reading

Baltic Horizon Fund publishes its NAV for June 2023

The net asset value (NAV) of the Baltic Horizon Fund (the Fund) unit at the end of June 2023 amounted to EUR 0.9905 per unit. Compared to the previous month, NAV per unit decreased by 10.4%. The total net asset value of the Fund amounted to EUR 118.5 million over the month. The NAV decrease was mainly affected by the mid-year revaluation of investment properties. The EPRA NRV as of 30 June 2023 was EUR 1.0208 per unit, corresponding to a decrease of 11.8% over the last month. At the end of June 2023, new portfolio valuations were conducted by an independent real estate appraiser Colliers. As of 30 June 2023, the fair value of the Baltic Horizon Fund portfolio decreased to EUR 255.7 million (like-for-like portfolio as of 31 December 2022: 268.9 million). Compared to the previous valuations, the change in portfolio value was mainly driven...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.